Klinbeforsk
10
5
8
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.4% vs industry average
40%
4 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Proton Versus Photon Therapy in Head and Neck Squamous Cell Carcinomas.
Role: collaborator
Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial
Role: collaborator
The National Lipedema Study
Role: collaborator
Thrombolysis in Factor Xa-inhibitors Trial
Role: collaborator
Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer
Role: collaborator
Aspirin in Colorectal Cancer Liver Metastases
Role: collaborator
Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer
Role: collaborator
The NAD-HD Study: A Study to Investigate Efficacy and Safety of Nicotinamide Riboside Compared With Placebo in Huntington's Disease
Role: collaborator
Prevention of Cardiac Dysfunction During Breast Cancer Therapy
Role: collaborator
The Norwegian Antibiotics for Pneumonia in Children Study
Role: collaborator
All 10 trials loaded